Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19

• Ngā kaituhi matua: Vikas P. Sukhatme (Author), Angela M. Reiersen (Author), Sharat J. Vayttaden (Author), Vidula V. Sukhatme (Author)
• Hōputu: Pukapuka
• I whakaputaina: Frontiers Media S.A., 2021-04-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Fluvoxamine is a well-tolerated, widely available, inexpensive selective serotonin reuptake inhibitor that has been shown in a small, double-blind, placebo-controlled, randomized study to prevent clinical deterioration of patients with mild coronavirus disease 2019 (COVID-19). Fluvoxamine is also an...